[EN] STING AGONIST COMPOUNDS [FR] COMPOSÉS AGONISTES DE STING
摘要:
The present disclosure is related to STING agonists, pharmaceutical compositions thereof, and the use of the agonists and pharmaceutical compositions to induce a STING-mediated immune response and/or to treat diseases and disorders mediated by STING, such as cellular proliferative disorders, including, but not limited to, cancer.
Derivatives of naphthalene with comt inhibiting activity
申请人:——
公开号:US20040034011A1
公开(公告)日:2004-02-19
Compounds of formula (I′), wherein A, R
1
to R
3
and t are as defined in the disclosure, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.
Derivatives of naphthalene with COMT inhibiting activity
申请人:Bäckström Reijo
公开号:US06903114B2
公开(公告)日:2005-06-07
Compounds of formula (I′), wherein A, R
1
to R
3
and t are as defined in the disclosure, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.
DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY
申请人:ORION CORPORATION
公开号:EP1317411A1
公开(公告)日:2003-06-11
US6903114B2
申请人:——
公开号:US6903114B2
公开(公告)日:2005-06-07
[EN] DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY<br/>[FR] DERIVES DE LA NAPHTHALENE PRESENTANT UNE ACTIVITE D'INHIBITION DE L'ENZYME COMT
申请人:ORION CORP
公开号:WO2002022551A1
公开(公告)日:2002-03-21
Compounds of formula (I') wherein A, R1 to R3 and t are as defined in claims, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.